Pds Biotechnology Corp Stock Analysis

PDS Stock Analysis Notes

About 23.0% of the company shares are owned by institutional investors. The book value of PDS Biotechnology was at this time reported as 0.79. The company recorded a loss per share of 1.39. PDS Biotechnology Corp last dividend was issued on the 18th of March 2019. The entity had 1:20 split on the 18th of March 2019. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey. Pds Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people. To find out more about PDS Biotechnology Corp contact Frank BeduAddo at 800 208 3343 or learn more at https://www.pdsbiotech.com.

PDS Biotechnology Corp Investment Alerts

PDS Biotechnology Corp Upcoming and Recent Events

PDS Largest EPS Surprises

View All Earnings Estimates

PDS Stock Institutional Investors

Note, although PDS Biotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

PDS Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 109.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PDS Biotechnology's market, we take the total number of its shares issued and multiply it by PDS Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

PDS Profitablity

Management Efficiency

PDS Biotechnology Corp has return on total asset (ROA) of (0.3945) % which means that it has lost $0.3945 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2246) %, meaning that it created substantial loss on money invested by shareholders. PDS Biotechnology's management efficiency ratios could be used to measure how well PDS Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. As of April 23, 2024, Return On Tangible Assets is expected to decline to -0.76. In addition to that, Return On Capital Employed is expected to decline to -0.99. At present, PDS Biotechnology's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 63.4 M, whereas Non Current Assets Total are forecasted to decline to about 318.3 K.

Technical Drivers

As of the 23rd of April, PDS Biotechnology holds the Coefficient Of Variation of (1,474), market risk adjusted performance of (0.10), and Risk Adjusted Performance of (0.03). Concerning fundamental indicators, the technical analysis model allows you to check practical technical drivers of PDS Biotechnology, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We are able to interpolate and collect thirteen technical drivers for PDS Biotechnology Corp, which can be compared to its competitors. Please check PDS Biotechnology Corp standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if PDS Biotechnology Corp is priced more or less accurately, providing market reflects its current price of 3.2 per share. Given that PDS Biotechnology has information ratio of (0.08), we recommend you to check out PDS Biotechnology Corp's recent market performance to make sure the company can sustain itself at some point in the future.

PDS Biotechnology Corp Price Movement Analysis

PDS Biotechnology Corp Insider Trading Activities

PDS Biotechnology Predictive Daily Indicators

PDS Biotechnology Corporate Filings

PDS Biotechnology Forecast Models

PDS Biotechnology's time-series forecasting models are one of many PDS Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PDS Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how PDS Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PDS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PDS Biotechnology. By using and applying PDS Stock analysis, traders can create a robust methodology for identifying PDS entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PDS analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PDS analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

PDS Biotechnology Corp stock analysis indicators help investors evaluate how PDS Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading PDS Biotechnology shares will generate the highest return on investment. By understating and applying PDS Biotechnology stock analysis, traders can identify PDS Biotechnology position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

When running PDS Biotechnology's price analysis, check to measure PDS Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PDS Biotechnology is operating at the current time. Most of PDS Biotechnology's value examination focuses on studying past and present price action to predict the probability of PDS Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PDS Biotechnology's price. Additionally, you may evaluate how the addition of PDS Biotechnology to your portfolios can decrease your overall portfolio volatility.

Is PDS Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. If investors know PDS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PDS Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of PDS Biotechnology Corp is measured differently than its book value, which is the value of PDS that is recorded on the company's balance sheet. Investors also form their own opinion of PDS Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is PDS Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PDS Biotechnology's market value can be influenced by many factors that don't directly affect PDS Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PDS Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if PDS Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PDS Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.